U.S. Banks Stock News

In early May 2026, Caris Life Sciences reported first-quarter revenue of US$216.17 million versus US$120.92 million a year earlier, with net loss improving to US$0.51 million, while also securing MolDX approval for its Caris ChromoSeq whole genome assay and launching the AI-driven Caris MI Clarity breast cancer prognostic test. Together, these developments highlight Caris’ efforts to broaden its precision oncology portfolio across hematologic malignancies and early-stage breast cancer, while...

Sana Biotechnology, Inc. recently drew attention with heavy pre-earnings options activity and elevated implied volatility, ahead of its first-quarter earnings release and its past May 12, 2026 presentation at the BofA Securities Healthcare Conference. Investors are closely watching how Sana’s engineered cell therapy pipeline, including its collaborations with Beam Therapeutics and Mayo Clinic, might feature in these updates. We’ll now examine how this heightened options activity ahead of...

Wondering whether NCR Voyix at US$8.09 is starting to look cheap, or still carries too much risk for the price you pay? The stock has moved sharply in the short term, with a 17.4% return over 7 days and 29.2% over 30 days, although returns are negative at 18.0% year to date and 20.4% over 1 year. These recent moves sit against a longer track record that includes 42.7% and 71.8% returns over 3 and 5 years respectively. These figures may reflect shifting sentiment and changing expectations for...

Why Catalyst Pharmaceuticals Stock Is On Investors’ Radar Catalyst Pharmaceuticals (CPRX) has drawn attention after a period of strong share-price moves, with returns over the past month, past 3 months and year all in positive territory according to recent performance data. For investors tracking US biopharmaceutical stocks focused on rare diseases, this kind of sustained positive return profile can prompt a closer look at how the current share price relates to earnings, profitability and...

Jacobs Solutions (NYSE:J) has been selected as part of a joint venture to design five new underground stations for Sydney Metro West. The contract covers integrated engineering design services for Australia’s largest transportation project. The win expands Jacobs Solutions’ global transportation infrastructure footprint, with a focus on high-performance, sustainable mass transit. For investors watching the infrastructure and engineering space, this new Sydney Metro West mandate puts Jacobs...

Stepan Company reported past first-quarter 2026 results showing sales of US$604.51 million versus US$593.26 million a year earlier, but it swung from net income of US$19.71 million to a net loss of US$41.41 million, with basic and diluted loss per share from continuing operations of US$1.81 compared with earnings of US$0.86. Despite the move into loss-making territory, Stepan maintained its shareholder payout by affirming a quarterly dividend of US$0.395 per share, payable on June 15, 2026,...

IHS Holding (NYSE:IHS) has completed the divestment of its 51% stake in Brazilian fiber infrastructure venture I-Systems. The stake has been sold to TIM S.A., marking IHS Holding's exit from this Brazilian optical fiber joint venture. IHS Holding, trading at $8.23, has seen its stock return 12.0% year to date and 44.1% over the past year, while its 3 year return stands at 9.2%. This completed I-Systems divestment gives investors a fresh development to consider alongside those share price...

Albemarle (NYSE:ALB) held its annual shareholder meeting on May 5, 2026. Shareholders approved the board slate, executive compensation package, and auditor ratification. A proposal to remove supermajority provisions for certain affiliated transactions narrowly did not pass. Shareholders backed a proposal to make it easier for investors to call special meetings. Albemarle, a major producer in the lithium and specialty chemicals space, sits at the center of debates around corporate governance...

Wondering if Maximus stock is offering fair value or a potential bargain right now, especially after a tough stretch for returns. The share price last closed at US$66.66, with Maximus delivering a 1.6% return over the past week and 2.3% over the last month, but a 22.9% decline year to date and a 10.6% decline over the last year hint at changing sentiment. Recent coverage has focused on how Maximus fits into investors' long term portfolios and whether the current price reflects its...

RenaissanceRe Holdings (NYSE:RNR) has appointed Henry Klehm III as Non-Executive Chair, succeeding the company’s long-serving board leader. The board also renewed its share repurchase program, authorizing up to $750 million of buybacks. These moves highlight changes in board oversight and capital allocation at a time when the stock trades around $300.84. RenaissanceRe Holdings comes into this leadership change with the stock at $300.84 and multi year share price gains, including 10.5% year...

If you are wondering whether DNOW stock offers value at today’s price, the key question is how that price lines up with the company’s underlying fundamentals. The stock last closed at US$13.05, with returns of 6.3% over 30 days, a 3.3% decline over 7 days, a 2.3% decline year to date, and a 10.2% decline over 1 year. The 3 year and 5 year returns sit at 43.1% and 19.8% respectively. These mixed returns highlight that sentiment around DNOW can shift over different time frames. This often...

If you are wondering whether Dynex Capital's current share price offers good value or carries more risk than reward, the starting point is to look closely at how it stacks up on valuation. The stock recently closed at US$13.32, with a 7 day return of 2.2% decline, a 30 day return of 5.0%, a year to date return of 5.4% decline, and a 1 year return of 25.5%, which gives you a mix of short term setbacks and longer term gains to weigh up. Recent coverage around Dynex Capital has focused on how...

Xeris Biopharma Holdings (XERS) stock is in focus after the company reported a profitable first quarter of 2026 and raised its full year revenue guidance to US$380 million to US$390 million. See our latest analysis for Xeris Biopharma Holdings. The guidance hike and first quarter profit have come after a mixed period for the stock, with a 12.95% 1 month share price return and a 9.80% year to date share price decline. At the same time, 1 year and 3 year total shareholder returns of 28.49% and...

Rising inflation surprises, volatile energy and food prices, and mixed signals on growth are keeping markets jumpy, while the world’s appetite for electricity-intensive AI and low carbon power keeps building. For investors, that combination puts long term, round the clock clean energy at the center of many big spending plans. The Nuclear Renaissance screener focuses on companies tied to this push for reliable, carbon free power linked to major infrastructure commitments rather than short term...

If you are wondering whether Genpact at around US$34.48 is a bargain or a value trap, the key is understanding what the current price really reflects. Over the short term, the stock has seen a 0.8% decline over 7 days, an 8.0% decline over 30 days, and is down 24.9% year to date, with a 16.6% decline over 1 year and a near flat 0.3% return over 3 years, compared with a 17.0% decline over 5 years. Recent coverage around Genpact has focused on how the business is positioned in professional...

What Republic Airways Holdings (RJET) Offers Investors Today Republic Airways Holdings (RJET) operates scheduled passenger services with about 275 aircraft and 1,300 daily flights across 130 cities in the United States, Canada, the Caribbean, and Mexico. The company reported revenue of US$1,809.1 million and net income of US$76.0 million. The stock most recently closed at US$22.39, with reported returns of 10.51% over the past day, 34.39% over the past week, 21.82% over the past month, and...

SES AI stock performance snapshot SES AI (SES) has drawn fresh attention as investors reassess high risk battery technology stocks, with the share price recently closing at US$0.92 and the market cap sitting near US$362.7m. See our latest analysis for SES AI. The recent 1 day share price return of a 6.24% decline, alongside a 7 day share price return of a 12.29% decline and a 90 day share price return of a 51.01% decline, contrasts with a 1 year total shareholder return of 2.19%. This...

Q1 2026 earnings put Eve Holding in focus Eve Holding (EVEX) is back on investors’ radar after reporting a wider first quarter 2026 loss, updating its eVTOL commercialization timeline, and outlining progress on certification and prototype flight testing. See our latest analysis for Eve Holding. The earnings update and prototype milestones have come after a mixed run for the stock, with a 24.9% 1 month share price return but a 23.39% year to date share price decline and a 59.82% 3 year total...

In the past quarter, MasterBrand, Inc. reported Q1 2026 sales of US$618 million, down from US$660.3 million a year earlier, and moved from a net income of US$13.3 million to a net loss of US$15.4 million. Alongside weaker results, the company guided to a further mid- to high-single-digit year-over-year sales decline for Q2 2026 and confirmed it repurchased 226,914 shares under its 2025 buyback plan while advancing cost cuts and tariff mitigation as it works toward a merger with American...

IDACORP, Inc. reported past first-quarter 2026 results showing sales of US$402.76 million and net income of US$67.98 million, with diluted EPS from continuing operations of US$1.21, up from US$1.10 a year earlier. Alongside reaffirming its full-year 2026 earnings guidance of US$6.25 to US$6.45 per diluted share, the company expects Idaho Power to use less than US$30 million of additional tax credits under its Idaho regulatory mechanism, assuming normal weather and power supply expenses. We...

In recent months, multiple law firms have launched securities class action lawsuits against Power Solutions International, alleging false and misleading statements about its ability to meet data center sales demand and manage related manufacturing costs between May 2025 and March 2026. The wave of similar complaints highlights how disclosures about operational inefficiencies and gross margin pressure can rapidly shift legal, operational, and governance risks for shareholders. Next, we’ll...

Winmark (WINA) is in focus after the company outlined upcoming board changes, with long-serving director Lawrence A. Barbetta set to step down and marketing executive Stephanie S. Hoppe joining the board. See our latest analysis for Winmark. The board changes arrive after a softer run for the stock, with a 30-day share price return of a 13.0% decline and a 90-day share price return of an 18.7% decline. The 5-year total shareholder return of 120.1% points to much stronger longer term...

One of the biggest stories of last week was how Installed Building Products, Inc. ( NYSE:IBP ) shares plunged 25% in...

With inflation readings still elevated in many countries, bond yields reacting to every policy hint and trade flows shifting across regions, it is easy to feel stuck on the sidelines. One way to cut through the noise is to focus on founder-led companies where leadership has real skin in the game and capital is used carefully. This screener does exactly that, filtering for businesses where founders are still in charge and closely aligned with shareholders. In this article, you will see three...